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Background: There is agreement among GI society guidelines for recommending early oral nutrition with
non-liquid diet in patients with mild acute pancreatitis (AP). There is less agreement regarding
administration of tube feedings (TF) in AP. Data on physicians’ adherence to nutrition guidelines and
practice variations are limited.
Aims: To report practice patterns in the nutritional management of different severity profiles of AP.
Methods: We conducted an anonymous electronic survey among physician members of the International
Association of Pancreatology and the American Pancreatic Association. We assessed nutrition practices
based on severity of AP, and asked relevant questions regarding the preferred administration strategies
for enteral nutrition. Responses were compared by practice location and subspecialty.
Results: A total of 178 physicians, mostly medical pancreatologists (40.4%) and surgeons (34.8%) from
Europe (43.4%) and North America (32%) responded. Overall, only 26.7% initiated oral nutrition in mild
AP on day 1, 40.9% waited >48 h, and 57.3% initiated nutrition with liquid diets. Physicians reported
frequently using TF in patients with moderately-severe (30e75%, depending on the amount and location
of necrosis) and severe AP (75e80%). Two-thirds of physicians preferred initiating TF after 48 h,
administering it post-pylorically, and using semi-elemental or polymeric formulas. Median TF duration
was 11 days (IQR, 7e21). Significant variations were noted based on geographic location and physician
subspecialty for several aspects of nutritional practices in both mild and non-mild AP.
Conclusion: Adherence to oral nutrition guideline recommendations for mild AP is low. There is signif-
icant variability in the use of TF in AP. Our study highlights opportunities for improving consistency of
nutrition care in AP and identify potential areas for research.
© 2021 Published by Elsevier B.V. on behalf of IAP and EPC.Introduction
Acute pancreatitis (AP) is one of the leading gastrointestinal
causes for hospitalization - in 2014, there were 279,145 inpatient
admissions for AP in the US alone [1]. The majority of patients withy & Hepatology, University of
-wing, Pittsburgh, PA, 15213,
lf of IAP and EPC.AP have mild disease, but ~20e30% develop local or systemic
complications, and ~1e3% have a fatal outcome [2e4]. For patients
with mild AP, early initiation of oral feeding (<48 hours [h]), with
soft or solid diets of low- or full-fat content, has demonstrated to
shorten hospital stay, reduce healthcare costs, and be equally safe
and tolerated than late initiation of feedings or with liquid diets
[5e9]. Therefore, GI society guidelines have endorsed early onset of
oral nutrition with a non-liquid diet in patients with mild AP
[10e14]. Current evidence does not support one non-liquid diet
over the others, and thus, guidelines provide different low-level
recommendations in this aspect.
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moderately-severe and severe AP [3,15]. There is consensus across
society guidelines that enteral tube feedings (TF) should be
preferred over parenteral nutrition (PN) in patients with AP who
need nutritional support [10e14,16]. However, there is a lack of
clarity regarding the timing of TF initiation (i.e. early [<48 h],
delayed [48e120 h] or on-demand), route of administration
(nasogastric [NG], nasojejunal [NJ]), and the composition of TF
(elemental, semi-elemental, polymeric, immune-modulating), pri-
marily due to insufficient evidence to conclude superiority of any
one of these interventions over other(s) [17,18]. Hence, while some
guidelines recommend administering TF through either a NG or NJ
tube, and refrain from recommending a timing of initiation or
composition of TF [10,12,13], others are more specific in providing
recommendations on first-line TF strategies, such as early onset
[11,14,16], NG tube [11], NJ tube [14], monomeric formula [16], or
polymeric formula [11].
The heterogeneity across different guideline recommendations
provides a rationale to assess the current clinical practice patterns
across physicians. This can provide insights into areas where
guidance is limited, such as the type of discharge diet in mild AP,
the need of TF in specific phenotypes based on severity, and the
duration of TF. Furthermore, understanding the variations in
practice patterns, overall, by geography and subspecialty practice,
may help to identify areas in need for more consistent high quality
care, and to generate hypotheses for empiric evaluation in future
research studies. Therefore, the objectives of this survey-based
study were: 1) report current practice patterns in the nutritional
management of patients with AP stratified by severity; and 2)




This study included a prospective two-phase survey instrument
development and distribution performed between October, 2017
and November, 2019. The study was approved by the Colorado
Multiple Institutional Review Board (COMIRB 18e0634).
Study population
The target population was physicians with clinical practices
focusing on management of patients with AP. For this reason, the
source population included active physician members of the In-
ternational Association of Pancreatology (IAP) and the American
Pancreatic Association (APA).
Survey instrument development
First, a comprehensive literature review informed generation of
potentially relevant questions of interest. Next, a mixed-methods
approach was used to create the survey instrument. Content val-
idity was established after independent survey review by five in-
ternational experts in AP. Pilot testing was then performed by ten
experts in the field that informed the final version of the survey.
The survey (Supplementary Appendix A) included demographic
questions such as practice location, medical specialty, type of
clinical practice, years of clinical experience, and yearly volume of
AP patients treated in the practice. Content related to nutrition
practices in AP consisted of 23-items, which addressed the
following domains: practice patterns in patients with mild AP;
practice patterns in patients with moderately-severe and severe
AP; and route of TF administration, method of tube placement, TF643formula and care after tube placement. Disease severity was
defined using the Revised Atlanta Classification [19]. Questions
about mild AP centered on the timing and type of initial and
discharge oral nutrition. For moderately-severe and severe AP, re-
spondents were asked to report the frequency of TF utilization
(from 0 to 100%) in different clinical scenarios of organ failure,
degree and location of necrosis. The onset of TF was classified as
early (within 24e48 h from presentation), delayed (after 48e72 h
of presentation), and on demand (only if failure to tolerate oral
nutrition, up to 5e7 days from presentation). The median duration
of TF and timing for cross-sectional images after TF initiation were
also assessed. Physicians were asked about their preferences for the
route of TF (NG, NJ, port-pyloric), placement of NJ tube (radiologi-
cally, endoscopically, bedside), and type of formula (elemental,
semi-elemental, polymeric, immune-modulating). Finally, re-
sponses were recorded on a five-point balanced Likert scale
(1¼most influential to 5¼ least influential) for factors that influ-
enced the decision for initiating TF in mild AP, and for selecting the
route of enteral nutrition (NG vs. NJ).
Survey distribution and data management
The survey was designed and conducted using REDCap
(Research Electronic Data Capture), a secure, web-based applica-
tion used to support data capture for research studies [20]. The
survey was first distributed by e-mail in March 2019. Monthly re-
minders were sent until November 2019, at which time the survey
was closed, and analysis was conducted. To ensure confidentiality,
each participant's information was de-identified.
Statistical analysis
The primary analysis was a descriptive assessment of individual
survey response items in different domains. Descriptive statistics
were reported as proportions for categorical data, and as median
(interquartile range [IQR]) for continuous data. Secondary analysis
evaluated differences in survey responses according to practice
location (North America vs. Europe) and subspecialty (medical
pancreatology vs. surgery). These univariate comparisons were
performed using chi-square test (or trend test when appropriate)
for categorical data and Wilcoxon rank-sum test for continuous
variables. Statistical significance was defined as p< 0.05. All sta-
tistical analyses were performed using Stata/SE version 15.1 (Col-
lege Station, TX) and missing data was not imputed.
Results
Demographic characteristics
A total of 178 physicians responded to the survey (76 Europe, 56
North America, 23 Asia, 13 Latin America, 7 Australia). Most phy-
sicians identified themselves as medical pancreatologists (40.4%)
and surgeons (34.8%). The majority practiced in an academic hos-
pital (85.4%), with >100 AP hospitalizations yearly (53.1%), and had
>10 years of clinical practice experience (72.4%) (Table 1).
Nutrition practice patterns in mild AP
Themajority of physicians start oral nutritionwithin the first 48 h
of admission (59.1%), although only 26.7% feel comfortable starting it
at day 1 (Table 2). Most physicians reported reintroducing oral
feedings with a liquid diet (clear 40.3%; full 17%), and only about a
quarter recommend starting with a solid diet (low fat 21%, regular
4.6%). At the time of discharge, the large majority of respondents
recommend a low fat diet (54%).When evaluating factors that lead to
Table 1
Information on clinical practice of survey respondents.
Variable (N¼ 178) N (%)
Practice location (n¼ 175)
Europe 76 (43.4)
North America 56 (32)
Asia 23 (13.1)
Latin America 13 (7.4)
Australia 7 (4)
Medical subspecialty
Medical Pancreatology 72 (40.4)
Surgery 62 (34.8)
Other 44 (24.7)
Advanced endoscopy 24 (13.5)
General gastroenterology 12 (6.7)
Other 8 (4.5)
Type of practice
Academic hospital 152 (85.4)
Community hospital 32 (18)
Private practice 16 (9)
Veteran administration hospital 2 (1.1)






Currently in training 4 (2.3)









Physician preferences and their nutrition practice patterns in patients with mild AP.
Characteristics All (N¼ 178) Europe (n¼ 76) North America
Day of starting oral diet (n¼ 176), n (%)
1 47 (26.7) 24 (31.6) 16 (29.6)
2 57 (32.4) 19 (25) 22 (40.7)
3 46 (26.1) 26 (32.2) 13 (24.1)
4 or more 26 (14.8) 7 (11.2) 3 (5.6)
Type of initial oral nutrition (n¼ 176), n (%)
Clear liquid 71 (40.3) 18 (23.7) 30 (55.6)
Full liquid 30 (17) 16 (21.1) 4 (7.4)
Soft 30 (17) 20 (26.3) 3 (5.6)
Low fat 37 (21) 17 (22.4) 14 (25.9)
Regular 8 (4.6) 5 (6.6) 3 (5.6)
Type of discharge oral nutrition (n¼ 176), n (%)
Full liquid 3 (1.7) 1 (1.3) 1 (1.9)
Soft 15 (8.5) 4 (5.3) 2 (3.7)
Low fat 95 (54) 35 (46.1) 36 (66.7)
Regular 63 (35.8) 36 (47.4) 15 (27.8)
Determinant factors of TF use (n¼ 155), n (%)
Intolerance to oral nutrition 78 (50.3) 30 (43.5) 29 (59.2)
Paralytic ileus 29 (18.7) 16 (23.2) 9 (18.4)
Persistent abdominal pain 15 (9.7) 2 (2.9) 6 (12.2)
Persistent SIRS 18 (11.6) 11 (15.9) 3 (6.1)
Prolonged hospital stay 15 (9.7) 10 (14.5) 2 (4.1)
Day of starting TF (n¼ 172), n (%)
1 9 (5.2) 5 (6.7) 1 (1.9)
2 27 (15.7) 11 (14.7) 7 (13.2)
3 44 (25.6) 19 (25.3) 14 (26.4)
4 or after 92 (53.5) 40 (53.3) 31 (58.5)
TF: tube feedings. Comparisons were performed using chi-square test.
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644physician decision for initiating TF, physicians place the greatest
importance on intolerance to oral nutrition (50.3%) and presence of
ileus (18.7%). A majority of physicians reported making a decision to
start TF after 3 days of admission (53.5%).
In subset analysis, when compared with Europe, North Amer-
ican physicians weremore likely to reintroduce oral feedings with a
clear liquid diet (55.6 vs. 23.7%, p< 0.0001). With regard to initia-
tion of TF, North American physicians place the most emphasis on
intolerance to oral nutrition (59.2% vs. 43.5%), whereas European
physicians were more likely to consider persistent systemic in-
flammatory response syndrome (15.9% vs. 6.1%) and length of stay
(14.5% vs. 4.1%, p¼ 0.029). Nutritional practice patterns were
mostly similar when stratified by specialty, except that pan-
creatologists felt more comfortable recommending a low fat diet as
the initial type of oral feedings (33.3% vs. 11.3%), whereas surgeons
opted more frequently for a full liquid diet (22.6% vs. 9.7%,
p¼ 0.013).Nutrition practice patterns in moderately-severe and severe AP
Physicians reported utilizing TF in 80% (IQR, 50e98%) of patients
with persistent multiple organ failure, 80% (IQR, 39e98%) with
persistent isolated respiratory failure, 75% (IQR, 25e97%) with
persistent isolated renal failure, and 75% (30e97%) with >50%
pancreatic necrosis without organ failure (Table 3). The proportion
of patients in which physicians utilize TF was 50% in the absence
of organ failure and with peripancreatic or smaller amount of ne-
crosis. The timing for initiation of TF was roughly divided equally
(about one-thirds each) between early, delayed and on-demand
onset strategies. Upon initiation of TF, physicians report obtaining
cross-sectional images at a median of 7 days (IQR, 6e14) and
administer TF for a median duration of 11 days (IQR, 7e21).(n¼ 56) P-value Pancreatology (n¼ 72) Surgery (n¼ 62) P-value
21 (29.2) 19 (30.7)
0.24 28 (38.9) 18 (29) 0.51
14 (19.4) 18 (29)
9 (12.5) 7 (11.3)
29 (40.3) 25 (40.3)
7 (9.7) 14 (22.6)
<0.0001 10 (13.9) 11 (17.7) 0.013
24 (33.3) 7 (11.3)
2 (2.8) 5 (8.1)
1 (1.4) 1 (1.6)
0.12 2 (2.8) 9 (14.5) 0.1
42 (58.3) 30 (48.4)
27 (37.5) 22 (35.5)
0.029 31 (47) 30 (56.6) 0.27
13 (19.7) 10 (18.9)
6 (9.1) 2 (3.8)
6 (9.1) 8 (15.1)
10 (15.1) 3 (5.7)
4 (5.7) 2 (3.3)
0.63 9 (12.9) 11 (18.3) 0.51
23 (32.9) 14 (23.3)
34 (48.5) 33 (55.1)
Table 3
Physician preferences and their nutrition practice patterns in patients with moderately-severe and severe AP.












Utilization of TF, median % (IQR)
Persistent multiple OF 80 (50e98) 85 (55e100) 90 (75e98) 0.63 84 (60e99) 80 (50e99) 0.63
Persistent isolated respiratory failure 80 (39e98) 80 (30e99) 86 (75e99) 0.07 78 (39e98) 85 (50e98) 0.32
Persistent isolated renal failure 75 (25e97) 75 (25e100) 75 (34e96) 0.52 73 (25e90) 80 (50e97) 0.23
>50% of pancreatic necrosis without OF 75 (30e97) 75 (30e100) 70 (50e90) 0.63 64 (30e95) 80 (41e97) 0.16
30e50% of pancreatic necrosis without OF 50 (20e95) 50 (15e94) 50 (25e90) 0.82 44 (13e82) 50 (25e90) 0.21
<30% of pancreatic necrosis without OF 30 (10e89) 30 (10e81) 27 (10e85) 0.69 20 (7e80) 39 (19e89) 0.06
Isolated peripancreatic necrosis without OF 30 (10e91) 20 (6e97) 28 (10e81) 0.90 24 (5e79) 30 (10e98) 0.31
Strategy to initiate TF (n¼ 174), n (%)
Early onset 58 (33.3) 27 (36.5) 13 (24.1) 19 (26.8) 23 (37.7)
Delayed onset 51 (29.3) 18 (24.3) 21 (38.9) 0.15 19 (26.8) 25 (41) 0.01
On demand 65 (37.4) 29 (39.2) 20 (37) 33 (46.5) 13 (21.3)
Timing of cross sectional imaging after initiation of feedings,
median days (IQR)
7 (6e14) 7 (5e12) 7 (7e21) 0.16 7 (6e20) 7 (6e10) 0.31
Duration of TF, median days (IQR) 11 (7e21) 10 (7e15) 15 (7e30) 0.004 11 (7e24) 12 (7e21) 0.86
TF: tube feedings; OF: organ failure; IQR: interquartile range.
J.D. Machicado, S. Wani, E. Quingalahua et al. Pancreatology 21 (2021) 642e648In subset analysis, the frequency of TF in patients with
moderately-severe and severe AP was similar in Europe and
North America, and by specialty. Physicians in North America
tend to continue TF for a longer duration compared to Europe
(median 15 vs. 10 days, p¼ 0.004). On the other hand, medical
pancreatologists reported preferring initiation of TF using an on-
demand strategy (46.5% vs. 21.3%) more often when compared
with surgeons who preferred early onset TF (37.7 vs. 26.8%)
(p¼ 0.01).Route, method of TF placement, TF formula and care post TF
placement
About two-thirds of physicians prefer administering post-
pyloric TF (nasojejunal 50.6%, anywhere post-pyloric 13.6%)
(Table 4). Among those preferring a NJ route, less pancreatic
stimulation (36.7%), better digestive tolerance (31.6%), and a better
safety profile (20.2%) were the most influential factors. The ma-
jority preferred placing the NJ endoscopically, with (34.9%) or
without (33.1%) fluoroscopic guidance. About one-third of physi-
cian favored TF via a NG (35.8%). Among them, the most influential
factors for this choice were data supporting similar outcomes
(38.8%), easy placement (27.7%) and immediate access (12.9%). Af-
ter excluding 30 participants who did not know the type of TF used
in their practice, the majority reported using semi-elemental
(38.6%) or polymeric (34.5%) formulas. Re-initiation of oral nutri-
tion after TF was equally distributed between liquid and solid food,
with only a small fraction of physicians initiating a regular diet.
In subset analysis, endoscopic placement of an NJ tube was
preferred by European physicians when compared to North
American physicians (83.8 vs. 52.8%, p< 0.001), and by pan-
creatologists when compared to surgeons (74.3 vs. 57.3%,
p¼ 0.012). When the factors that influenced the use of NJ tubes
were compared, pancreatologists placed greater importance on
reduced pancreatic stimulation (45.7 vs. 22.2%), in contrast to sur-
geons, who emphasized more on TF tolerance (51.6 vs. 27.3%)
(p¼ 0.043). In addition, pancreatologists were more likely to use a
semi-elemental formula (45 vs. 32.7%), while surgeons reported
higher utilization of immune-modulating formulas (15.4 vs. 0%,
p¼ 0.012). Responses from physicians in Asia and Latin America are
summarized in Supplementary Table 1; however, their number was
small for meaningful comparisons with European and North
American physicians.645Discussion
Our survey provides a snapshot of the current nutrition practice
patterns in AP among an international group of predominantly
North American and European physicians from high-volume aca-
demic centers. We found variability in several areas of clinical
practice, which in part, was explained by geographic location and
subspecialty practice. Our observations provide empiric data that
may help to identify areas where quality improvement in-
terventions are needed to improve adherence to evidence-based
practice guidelines and for future research directions.
Many RCTs have evaluated various aspects of the nutrition of AP
patients and their results have been translated into different
evidence-based guidelines (Supplementary Table 2) [5e9,17,21e26].
Early reinitiation of oral nutrition with a non-liquid diet is recom-
mended by several published guidelines for mild AP [10e13], with
some variability on when to refeed (e.g. within 24 h10, as soon as
tolerated [11e14]) and the type of non-liquid nutrition (e.g. low-fat
soft [11] or solid [12], unspecified [10,13,14]). Quality indicators,
that aim to measure the performance of care delivered to AP pa-
tients, were recently published by a panel of GI experts, and
endorsed by a quality measures committee of the American
Gastroenterological Association [27,28]. They proposemeasuring the
percent of adult AP patients who receive oral feeding within 24 h of
admission as a quality indicator; however, no threshold has been
suggested. There is less agreement among RCTs and guidelines
regarding several aspects of enteral TF nutrition in AP [10e14,16].
With regards to the timing of TF initiation, some guidelines recom-
mend early onset [11,14,16], whereas others refrain from making a
recommendation based on results of high-quality RCTs
[10,12,13,21,22]. Some guidelines recommend administering TF us-
ing a NG or NJ tube [10,12,13], based on results from RCTs that do not
support one feeding tube over the other [23e25], while other
guidelines specifically support a particular approach [11,14]. Most
guidelines do not provide recommendations on the composition of
TF as a consequence of multiple RCTs showing negative results
[10,12,13,26], although some guidelines recommend using mono-
meric or polymeric formulas [11,16].
We found noncompliance with oral nutrition guidelines in mild
AP to be common. Specifically, only 27% of clinicians adhered to early
oral nutrition within 24 h and 41% kept patients nil per os for over
48 h. Compliancewith initiating a non-liquid diet was also low (43%)
and highly variable by practice location, e.g. physicians practicing in
North America and surgeons more commonly use a liquid diet first,
Table 4















Preferred route of administration (n¼ 162), n (%)
NJ 82 (50.6) 36 (50.7) 29 (56.8) 31 (46.3) 31 (51.7) 0.95
Anywhere past the ligament of Treitz 51 (31.5) 19 (26.8) 21 (41.2) 0.32 19 (28.4) 19 (31.7)
At least 20 cm past the ligament of Treitz 31 (19.1) 17 (23.9) 8 (15.6) 12 (17.9) 12 (20)
NG 58 (35.8) 25 (35.2) 14 (27.5) 26 (38.8) 21 (35)
Post-pyloric (anywhere past the pylorus) 22 (13.6) 10 (14.1) 8 (14.3) 10 (14.9) 8 (13.3)
Most important factor to prefer NG TF (n¼ 54), n (%)
Easy placement 15 (27.7) 7 (30.4) 2 (15.4) 7 (29.2) 5 (26.3)
Similar outcomes 21 (38.8) 9 (39.1) 7 (53.8) 0.37 9 (37.5) 7 (36.8) 0.94
Immediate access 7 (12.9) 5 (21.7) 1 (7.7) 4 (16.7) 2 (10.5)
Lower cost 9 (16.6) 2 (8.7) 2 (15.4) 3 (12.5) 4 (21.1)
Similar safety profile 2 (3.7) 0 1 (7.7) 1 (4.2) 1 (5.3)
Most important factor to use NJ TF (n¼ 79), n (%)
Less pancreatic stimulation 29 (36.7) 11 (30.6) 14 (48.3) 16 (45.7) 6 (22.2)
Better tolerance of feedings 25 (31.6) 13 (33.3) 11 (37.9) 0.35 9 (27.3) 16 (51.6) 0.043
Better safety profile 16 (20.2) 9 (23.7) 5 (16.1) 7 (20.6) 7 (25)
More comfortable for the patient 7 (8.9) 4 (10.5) 1 (3.3) 3 (8.6) 1 (3.7)
Convenient outpatient use 2 (2.5) 2 (5.6) 0 0 1 (3.7)
Insertion method of NJ tube (n¼ 172), n (%)
Endoscopically 117 (68.0) 62 (83.8) 28 (52.8) <0.001 52 (74.3) 60 (57.3) 0.012
With fluoroscopic guidance 60 (34.9) 24 (32.4) 22 (41.5) 30 (42.9) 11 (18)
Without fluoroscopy 57 (33.1) 38 (51.4) 6 (11.3) 22 (31.4) 24 (39.3)
Fluoroscopically without endoscopy 32 (18.6) 5 (6.8) 12 (22.6) 12 (17.1) 13 (21.3)
At the bedside without endoscopy or fluoroscopy 23 (13.4) 7 (9.4) 13 (24.5) 6 (8.6) 13 (21.3)
Type of TF formula (n¼ 145), n (%) a
Oligomeric or semi-elemental 56 (38.6) 25 (42.4) 19 (41.3) 0.31 27 (45.0) 17 (32.7) 0.012
Polymeric 50 (34.5) 22 (37.3) 15 (32.6) 19 (31.7) 18 (34.6)
Monomeric or elemental 30 (20.7) 6 (10.1) 10 (21.7) 14 (23.3) 9 (17.3)
Immune-modulating 9 (6.2) 6 (10.1) 2 (4.4) 0 (0) 8 (15.4)
Type of oral nutrition after TF (n¼ 173), n (%)
Clear liquid 46 (26.6) 13 (17.6) 16 (30.2) 14 (19.4) 17 (27.9)
Full liquid 38 (22) 20 (27) 9 (17) 0.039 16 (22.2) 14 (23) 0.032
Soft 43 (24.8) 23 (31.1) 7 (13.2) 18 (25) 16 (26.2)
Low fat 38 (22) 15 (20.3) 17 (32.1) 23 (31.9) 8 (13.1)
Regular 8 (4.6) 3 (4) 4 (7.5) 1 (1.4) 6 (9.8)
ER visit due to TF complications (n¼ 147), median % (IQR) 14 (5e39) 10 (1e20) 30 (15e50) <0.001 13 (4e30) 11 (7e50) 0.60
Unexpected admission due to TF complications (n¼ 115), median
% (IQR)
10 (2e17) 6 (1e12) 16 (10e30) <0.001 9 (2e25) 10 (5e16) 0.60
NG: nasogastric; NJ: nasojejunal; TF: tube feedings; ER: emergency room; IQR: interquartile range.
a After excluding 30 survey respondents who did not know the type of TF used in their practice.
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more comfortable starting a soft or solid diet. Potential explanations
for practice variation may include personal beliefs regarding the
duration of “pancreas rest” needed, caution for exacerbating symp-
toms, or lack of awareness of current evidence. Other factors may
include diversity of hospital protocols, ambiguity in guideline rec-
ommendations, delayed translation of evidence into medical care, or
reluctance of physicians to comply with guidelines. Tailored in-
terventions may help overcome these barriers to allow wider
adoption of evidence-based guidelines. Physician education through
wider dissemination of educational material (e.g. mailing of rec-
ommendations, mass media, audiovisual material), national confer-
ences, local workshops, e-learning, and opinion leaders, is one of the
potential interventions. Benchmarking in this area can be used to
conduct audits, to generate performance feedback reports, and to
create incentives for high-performers; all of which can enhance
quality of care [29]. For this reason, consensus documents and
quality indicators should propose minimal thresholds for oral
nutrition practices in mild AP, taking into consideration the vari-
ability in clinical presentation and course, e.g. patients with ileus or
frequent vomiting may not tolerate early non-liquid diet.
In terms of enteral nutrition, we noted that the utilization of TF
in patients with moderately-severe and severe AP was high, and it646increased based on the amount of necrosis and presence of
persistent organ failure. The lack of universal use of TF in patients
with respiratory or multiorgan failure is notable, and may be
explained by preferential use of PN, clinical improvement before TF
initiation, or the lack of local expertise in enteral nutrition. Ours is
the first study to report the proportion of patients across the
spectrum of AP severity who receive TF in clinical practice across
geographic regions and specialty. In the absence of data, results of
this survey may help in setting benchmarks for future guidelines
and quality measures for enteral nutrition in moderately-severe
and severe AP.
Our results demonstrate variability in three areas of enteral
nutrition practices, for which no clear guidelines exist e timing of
TF initiation, timing of follow-up cross-sectional images, and
duration of TF. The strategy to initiate TF was roughly divided
equally between early-onset, delayed onset, and on-demand
enteral nutrition; although, medical pancreatologists waited more
than surgeons to decide initiation of TF. Preference for delayed or
on-demand TF over early TF initiation may be influenced by similar
outcomes in RCTs [21,22], safety concerns with early TF [30], and
suboptimal methods for early prediction of AP severity [31]. Phy-
sicians preferred to obtain cross-sectional imaging at a median of 7
days, and administer TF for a median of 11 days. Physicians in North
J.D. Machicado, S. Wani, E. Quingalahua et al. Pancreatology 21 (2021) 642e648American reported continuing TF for a longer duration when
compared with their European counterparts. These time points
may be aided by results of randomized clinical trials conducted for
TF initiation, where frequent oral challenges were offered early, and
TF lasted for 1 week [21,22]. Since the Revised Atlanta Classification
suggests waiting for ~4 weeks to determine the status of local
complications (e.g. transition of acute necrotic collections to
walled-off necrosis), performing cross-sectional imaging at 3e4
weeks after presentation, unless warranted otherwise by clinical
need, and administering TF for an average of ~4 weeks should be a
consideration [15,32].
There are no uniform societal recommendations for the route of
TF administration and the type of formula to use [10e14]. About
two thirds of physicians reported post-pyloric administration of TF,
inserting NJ tubes endoscopically, and using semi-elemental or
polymeric formulations, with variations based on practice location
andmedical subspecialty.When exploring factors guiding the route
of administration, physicians opting an NJ route used less pancre-
atic stimulation and better digestive tolerance as their rationale,
although the former is only based on anecdotal evidence and is not
evidence-based. In contrast, those preferring NG tubes supported
their decision on similar outcomes and easy placement. Potential
reasons explaining the preferences for NJ tube insertion method
and TF composition may depend on anecdotal experience and local
availability of resources. Appropriately powered multicenter RCTs
that compare the efficacy, safety, indications, and cost-effectiveness
of these TF strategies are needed, however, these are difficult,
intense, and expensive to conduct [17].
Our study is not without limitations. We did not have infor-
mation on the total membership of the APA and IAP, and the frac-
tion of members who are practicing clinicians to calculate the
survey response rate to assess for non-response bias. However, we
speculate response rate was low, based on a meta-analysis that
found low response rate of 38% when using online surveys among
healthcare professionals [33]. Participation of physicians from Asia,
Australia, or Latin America, and non-academic institutions, was
limited, which precluded our ability to conduct meaningful com-
parisons with other groups, and may affect the generalizability of
our results. In the absence of patient level data, it is possible that
physician survey responses might not accurately reflect their actual
clinical practice patterns, and some practices may be over-
represented in our sample due to survey completion by more
than one physician. Intrinsic to the use of a cross-sectional survey
design is recall and reporting biases, which could have led to
misclassification of measurements. Although the survey instru-
ment was rigorously designed, internal consistency and reliability
(test-retest or inter-rater) were not measured. Furthermore, the
survey was in English and not translated to other languages, which
may have caused selection bias and response bias in participants
from non-native English speaking countries.
Despite the above limitations, strengths of our study are the
inclusion of a large panel of physicians from 5 continents, and
systematic evaluation of several nutrition management strategies
for different severity phenotypes of AP. The use of a survey design
allowed us to efficiently obtain large amounts of real-world data in
a short period of time despite the lack of financial support for the
study.
In conclusion, most clinicians do not adhere to guidelines for
timing of initiation and type of oral nutrition in mild AP, which may
potentially delay hospital discharge and increase costs. TF are
commonly administered in patients with moderately-severe and
severe AP, are usually initiated after 48 h, administered post-
pylorically, with semi-elemental or polymeric formulas, and for a
median duration of 11 days. Nutrition practice patterns vary based
on geographic location and physician subspecialty, which in part647may reflect uncertainties in published literature and guidelines.
Since this survey is mostly representative of expert physicians
managing patients with AP, our study identifies opportunities for
improving consistency of care through education, provides empiric
data to inform quality indicators, and hypothesis generating ideas
for future research. Future studies using patient level data are
needed to confirm the practice patterns and preferences reported
in this international survey.
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